slides · global inventory
Turn
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 37,461
Current window 32,221-32,250
Pages 1,249
Rows per page 30
Beat
32,221-32,250 of 37,461
11
The slide describes a standard credit underwriting workflow.Ford Credit | FWP Presentation Deck | 13 slides · Ford Credit
Conference presentation Investor relations Beat · Solution1 hit
12
The slide describes the methodology for credit risk assessment and model governance.Ford Credit | FWP Presentation Deck | 13 slides · Ford Credit
Conference presentation Investor relations Beat · Solution1 hit
13
The slide outlines the purpose, variables, and operational application of behavioral scoring models, including a table of recent redevelopment dates.Ford Credit | FWP Presentation Deck | 13 slides · Ford Credit
Conference presentation Investor relations Beat · Solution1 hit
10
Includes a line chart showing treatment duration and a pie chart showing patient outcomes.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
11
Includes scatter plot for MMR correlation and bar chart for therapeutic index comparison.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
12
The slide outlines three strategic pillars (Drive Deeper Responses, Improve Tolerability, Enhance Safety & Convenience) and maps them to specific clinical development programs.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
13
Uses a before-after-bridge structure to contrast market limitations with product advantages.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
14
The chart uses a broken axis to represent the significantly larger patient population for HER2 overexpressing cancers compared to mutations.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
15
The chart uses a logarithmic scale for selectivity. The right side provides a qualitative critique of competitor molecules.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
16
Includes a list of abbreviations at the bottom.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
17
Imara | Mergers and Acquisitions Presentation Deck | 45 slidesImara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
18
Includes a stylized chemical structure graphic.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
19
Includes a timeline of key drug approvals and a survival probability chart.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
20
The slide uses a split-screen layout to contrast clinical challenges with the rationale for treatment switching.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
21
The slide uses a comparative table to frame the problem of current drug limitations, setting up a solution-oriented conclusion.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
22
Includes clinical trial data and resistance mutation analysis.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
23
The slide uses a split-screen layout to contrast current market realities with the company's vision, supported by a survival curve and a patient outcome pie chart.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
24
The slide uses a custom table structure to show competitive positioning of ELVN-001 against existing TKI generations.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
25
The slide outlines the strategic positioning of a drug candidate (ELVN-001) by contrasting its desired profile against current standards of care.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
26
Includes structural biology diagrams of BCR-ABL protein domains and a table comparing binding conformations.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
27
The table highlights key differentiators such as lower BCRP substrate status and improved plasma protein binding for ELVN-001.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
28
Includes both a competitive cellular phosphorylation table and a specific kinase selectivity table for ELVN-001.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
29
The slide uses a scatter plot for efficacy correlation and a bar chart for safety margin comparison.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
06
Features a brand ambassador, Monique Billings, to build social proof.Innovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations Beat · Solution1 hit
07
The slide highlights the company's competitive moat through IP and brand licensing.Innovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations Beat · Solution1 hit
08
Innovative Eyewear | Investor Presentation Deck | 21 slidesInnovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations Beat · Solution1 hit
09
The table uses checkmarks and X marks to visually demonstrate product differentiation.Innovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations Beat · Solution1 hit
10
The slide positions Vyrb as a competitor/alternative to Clubhouse and Discord, emphasizing hands-free audio posting.Innovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations Beat · Solution1 hit
10
KKR Real Estate Finance Trust | Results Presentation Deck | 25 slidesKKR Real Estate Finance Trust | Results Presentation Deck | 25 slides · KKR Real Estate Finance Trust
Conference presentation Investor relations Beat · Satisfaction1 hit
11
KKR Real Estate Finance Trust | Results Presentation Deck | 25 slidesKKR Real Estate Finance Trust | Results Presentation Deck | 25 slides · KKR Real Estate Finance Trust
Conference presentation Investor relations Beat · Satisfaction1 hit